Innovation Zed and A. Menarini Diagnostics Enter Commercial Agreement for Innovative medical accessory InsulCheck Connect

Dublin, Ireland, and Florence, Italy 28th January 2020

Innovation Zed, developer of novel Insulin Pen “InsulCheck Connect” add-on device, and A.Menarini Diagnostics, a leading diagnostics company, today announced a partnership to commercialize InsulCheck Connect device developed by Innovation Zed.

“We are very pleased with this announcement,” said John Hughes, CEO of Innovation Zed Ltd., “The relationships that A.Menarini Diagnostics has established with patients and healthcare providers in the diabetes community, and their extensive distribution expertise will positively position us to deliver to key international markets.”

The innovative InsulCheck Connect device was specifically chosen to integrate within A.Menarini Diagnostics’ connected diabetes care platform. According to the agreement, the two companies are forming a long-term partnership where A.Menarini Diagnostics will perform sales, marketing, training, and customer support, providing all necessary technical and clinical information for the correct use of the InsulCheck Connect device in regions around the globe including Europe.

“With this innovative product, healthcare providers and patients will have a powerful tool to take under control the blood glucose levels and prevent diabetes complications.” said Fabio Piazzalunga, General Manager and Global Head of A. Menarini Diagnostics. “This agreement is part of our strategy to develop a portfolio of fully integrated innovative products, allowing an enhanced management of diabetes for healthcare providers and an improved quality of life for patients.”

Dean Minnock, Director of Business Development and Third-Party Relationships at Innovation Zed Ltd., reaffirmed the comments above. Dean also stated:

“A. Menarini Diagnostics has established fantastic relationships with patients and healthcare providers and has extensive distribution expertise to effectively utilise InsulCheck Connect to greatly empower the diabetes community.”

In addition, A. Menarini Diagnostics. and Innovation Zed, Ltd. are discussing terms to commercialize additional innovative systems to improve the quality of life for patients with diabetes.